HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the completion of the sale, the senior vice president owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
HCA Healthcare Trading Down 0.1%
Shares of HCA Healthcare stock opened at $504.27 on Wednesday. The stock’s fifty day simple moving average is $447.20 and its 200 day simple moving average is $445.64. The company has a market capitalization of $105.34 billion, a PE ratio of 16.71, a PEG ratio of 1.69 and a beta of 1.11. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.96 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is presently 10.34%.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the stock. Morgan Stanley cut their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. BMO Capital Markets began coverage on HCA Healthcare in a research report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price objective for the company. Leerink Partners reissued an “outperform” rating and issued a $492.00 target price on shares of HCA Healthcare in a research report on Friday, September 18th. Wells Fargo & Company boosted their target price on HCA Healthcare from $381.00 to $468.00 and gave the company an “equal weight” rating in a research note on Monday, November 2nd. Finally, Bank of America upped their price target on HCA Healthcare from $450.00 to $500.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $480.13.
Read Our Latest Report on HCA Healthcare
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. MidFirst Bank acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $28,000. Clearstead Trust LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $29,000. Latitude Advisors LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $32,000. Delos Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the second quarter valued at $35,000. Finally, Laurel Wealth Advisors LLC acquired a new position in HCA Healthcare during the third quarter worth $40,000. 62.73% of the stock is owned by institutional investors and hedge funds.
HCA Healthcare Company Profile
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
